Noguchi Y, Tachi T, Teramachi H (2021) Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Brief Bioinform. 22:bbab347. https://doi.org/10.1093/bib/bbab347

Montastruc JL (2022) Pharmacovigilance and drug safety: fair prescribing and clinical research. Therapie 77:261–263. https://doi.org/10.1016/j.therap.2022.03.001

Article  PubMed  Google Scholar 

National Institute of Infectious Diseases, Vaccination schedule in Japan, April 1, 2018. https://www.niid.go.jp/niid/images/vaccine/schedule/2018/JP20180401_02.gif. Accessed Mar 2022.

Centers for Disease Control and Prevention, Immunization schedule, February 3 2020. https://www.cdc.gov/vaccines/schedules/index.html. Accessed Mar 2022.

Centers for Disease Control and Prevention, Estimates of influenza vaccination coverage among adults—United States, 2017–18 Flu Season. https://www.cdc.gov/flu/fluvaxview/coverage-1718estimates.htm. Accessed Mar 2022

Kaiser Family Foundation, Population distribution by age, https://www.kff.org/other/state-indicator/distribution-by-age/.Accessed Mar 2022.

Nobuhara H et al (2014) Estimation of influenza vaccination coverage ratio in Japan. Japanese J Public Health 61(7):354–359

PubMed  Google Scholar 

Ministry of Health, Labour and Welfare, Outline of the amendment of the Immunization Act, March 30, 2013. http://www.mhlw.go.jp/topics/bcg/tp250330-2.html.

The Law on Securing Quality, Efficacy and safety of products including pharmaceuticals and medical devices, Act No. 145 of 1960. http://www.japaneselawtranslation.go.jp/law/detail/?ft=1&re=01&dn=1&x=35&y=11&co=01&ia=03&ky=%E5%8C%BB%E8%96%AC%E5%93%81%E5%8C%BB%E7%99%82%E6%A9%9F%E5%99%A8&page=2

Code of Federal Regulations Title 21--Food and drugs chapter I--Food and Drug Administration, Department of Health and Human Services subchapter F--Biologics part 600 --biological products: general subpart D--reporting of adverse experiences Sec. 600.80 Postmarketing reporting of adverse experiences. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=600.80

Tobenkin, An introduction to drug safety surveillance and the FDA adverse event reporting system, April 2018. https://www.fda.gov/files/about%20fda/published/Drug-Safety-Surveillance-and-the-FDA-Adverse-Event-Reporting-System-%28PDF---1.31MB%29.pdf. Accessed Aug 2020

Inokuma Y, Sato Y, Matsuda S (2018) Adverse event reporting patterns of marketing authorization holders, healthcare professionals and patients in Japan: lessons learnt from the human papilloma virus vaccine. Pharmaceutical Medicine 32(2):123–129

Article  CAS  Google Scholar 

Japan Pharmaceutical Manufacturers Association, Protecting patients and its medicines –accumulation and utilization of safety information-, March 2008

Vaccine Adverse Event Reporting System, Table of reportable events following vaccination, March 2017. https://vaers.hhs.gov/docs/VAERS_Table_of_Reportable_Events_Following_Vaccination.pdf. Accessed Aug 2020

National Childhood Vaccine Injury Act of 1986 (42 U.S.C. §§ 300aa-1 to 300aa-34). https://uscode.house.gov/view.xhtml?path=/prelim@title42/chapter6A/subchapter19&edition=prelim

Food and Drug Administration, Guidance for industry postmarketing safety reporting for human drug and biological products including vaccines. March 2001. https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Draft-Guidance-for-Industry--Postmarketing-Safety-Reporting-for-Human-Drug-and-Biological-Products-Including-Vaccines.pdf. Accessed Aug 2020

Vaccine Adverse Event Reporting System, VAERS form, February 2020. https://wonder.cdc.gov/wonder/help/vaers/vaers_form_2.0.pdf. Accessed Aug 2020

Vaccine Adverse Event Reporting System, Front page of Vaccine Adverse Event Reporting System (VAERS). https://vaers.hhs.gov/. Accessed Aug 2020

Ministry of Health, Labour and Welfare, Form to report AEFI, 2018. http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/saishin.pdf#search=%27%E5%89%AF%E5%8F%8D%E5%BF%9C+%E6%A7%98%E5%BC%8F%27. Accessed Aug 2020.

Pharmaceuticals and Medical Devices Agency, Pilot and official implementation of patient AE reporting system. https://www.pmda.go.jp/files/000228628.pdf. Accessed Mar 2020

Final report of the committee for investigation of drug-induced hepatitis cases and appropriate regulatory administration to prevent recurrence of drug-induced suffering, April 28, 2010. http://www.mhlw.go.jp/shingi/2010/04/dl/s0428-8a.pdf. Accessed Aug 2020

Ministry of Health, Labour and Welfare, Starting patient adverse reporting system today. https://www.mhlw.go.jp/stf/newpage_04169.html. Accessed Aug 2020

Pharmaceuticals and Medical Devices Agenc, Front page of patient reporting system (PMDA). https://www.pmda.go.jp/safety/reports/patients/0024.html. Accessed Aug 2020

Vaccine Adverse Reactions Review Committee meeting material convened on March 23, 2018. http://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000199232.pdf. Accessed Aug 2020

Vaccine Adverse Event Reporting System, VAERS fact sheet. https://www.cdc.gov/vaccinesafety/00_pdf/09_207294_VAERS_FactSheet.pdf. Accessed Aug 2020

Vaccine Adverse Reactions Review Committee. https://www.mhlw.go.jp/stf/shingi/shingi-yakuji_127869.html, Accessed November 2020

Pharmaceuticals and Medical Devices Agency, Information about adverse events reported to PMDA. https://www.pmda.go.jp/safety/reports/patients/0002.html. Accessed Nov 2020

Vaccine Adverse Event Reporting System. https://vaers.hhs.gov/. Accessed Nov 2020

Gold MS, Gidudu J, Erlewyn-Lajeunesse M, Law B, (2010) Brighton Collaboration Working Group on Anaphylaxis, Can the Brighton Collaboration case definitions be used to improve the quality of adverse event following immunization (AEFI) reporting?: Anaphylaxis as a case study. Vaccine 28(28):4487–4498

Centers for Disease Control and Prevention, ACIP Committee Members, October 2019. https://www.cdc.gov/vaccines/acip/members/index.html. Accessed Aug 2020

Food and Drug Administration, Roster of the Vaccines and Related Biological Products Advisory Committee, April 2020. https://www.fda.gov/advisory-committees/vaccines-and-related-biological-products-advisory-committee/roster-vaccines-and-related-biological-products-advisory-committee. Accessed Aug 2020

Food and Drug Administration, FDA and CDC update on fluzone influenza vaccine and VAERS reports of febrile seizures in children, January 20, 2011. https://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm240037.htm. Accessed Aug 2020

Centers for Disease Control and Prevention, ACIP February 2011 summary meeting minutes. https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-feb11.pdf. Accessed Aug 2020

Food and Drug Administration, February 25, 2011: Vaccines and Related Biological Products Advisory Committee meeting transcript. https://wayback.archive-it.org/7993/20161024004521/http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/ucm249303.htm. Accessed Aug 2020

Ministry of Health, Labour and Welfare, Meeting material number 1, Joint meeting of the Vaccine Adverse Reactions Review Committee, 2020. https://www.mhlw.go.jp/content/10601000/000590703.pdf. Accessed Aug 2020.

Inokuma, Y and Kneller, K. Imprecision in adverse event reports following immunization against HPV in Japan and Covid-19 in the US, UK and Japan – and the effects of vaccine hesitancy and government policy. In preparation

Centers for Disease Control and Prevention, Health, United States, 2017. https://www.cdc.gov/nchs/data/hus/hus17.pdf. Accessed Aug 2020

United States Census Bureau, 2014 national population projections datasets. https://www.census.gov/programs-surveys/popproj/data/datasets.html. Accessed Aug 2020

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Clinical safety data management: definitions and standards for expedited reporting E2A. (1994)

Shimabukuro TT et al (2015) Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine 33(36):4398–4405

Larson HJ, de Figueiredo A, Zhao XH et al (2016) The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine 12:295–301. https://doi.org/10.1016/j.ebiom.2016.08.042. Accessed Mar 2022

Article  PubMed  PubMed Central  Google Scholar 

Abbott A (2006) Lyme disease: uphill struggle. Nature 439(7076):524–525

Article  CAS  PubMed  Google Scholar 

Nakajima H et al (2014) Healthcare professionals’ awareness of adverse effects on eyes caused by anticancer drugs. Iryoyakugaku 40(6):360–368

Google Scholar 

Japanese Society of Allergology, definition of anaphylaxis. https://www.jsaweb.jp/modules/stwn/index.php?content_id=7. Accessed Mar 2021

Turner PJ, Worm M, Ansotegui IJ et al (2019) Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organ J 12(10)

Center for Disease Control, Guillain-Barré syndrome and vaccine, August 14 2020. https://www.cdc.gov/vaccinesafety/concerns/guillain-barre-syndrome.html#. Accessed Nov 2020

Center for Disease Control, Estimates of flu vaccination coverage among children — United States, 2017–18 Flu Season, September 2018. https://www.cdc.gov/flu/fluvaxview/coverage-1718estimates-children.htm. Accessed Mar 2021

Tsuzuki S, Schwehm M, Eichner M (2018) Simulation studies to assess the long-term effects of Japan’s change from trivalent to quadrivalent influenza vaccination. Vaccine 36(5):624–630

Article  PubMed  Google Scholar 

Kusumi M et al (1995) Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture. Japan Psychiatry and clinical neurosciences 49(3):169–174

Article  CAS  PubMed  Google Scholar 

Health Action International, Direct patient reporting in the European Union: a snapshot of reporting systems in seven member states (2015). https://haiweb.org/wp-content/uploads/2015/09/Direct-Patient-Reporting-in-the-EU.pdf. Accessed Aug 2020

Van den Bemt PMLA et al (1999) Adverse drug events in hospitalized patients: a comparison of doctors, nurses and patients as sources of reports. Eur J Clin Pharmacol 55(2):155–158

Article  PubMed  Google Scholar 

Gäwert L, Hierse F, Zink A, Strangfeld A (2010) How well do patient reports reflect adverse drug reactions reported by rheumatologists? Agreement of physician-and patient-reported adverse events in patients with rheumatoid arthritis observed in the German biologics register. Rheumatology 50:152–160

PubMed  Google Scholar 

Egberts TCG et al (1996) Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ, 1996 313(7056):530–531

Sekine M et al (2020) Japan’s ongoing crisis on HPV vaccination. Vaccines 8(3):362